youtube_live
Q2 2027 earnings • in 3 days
See detailschevron_right
DIVISLAB:NSE
Divi's Laboratories Ltd
₹10,064.00
arrow_upward
+1.19%(+118.50) 1D
Nov 3, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DIVISLAB...
Open
₹9,965.00
High
₹10,064.00
Low
₹9,863.00
Mkt. cap
2.67T
Avg. vol.
589.35K
Volume
611.34K
Dividend
0.30%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
91.33
52-wk high
₹10,064.00
52-wk low
₹5,647.50
EPS
₹110.20
Shares outstanding
265.47M
No. of employees
12K
Open
₹9,965.00
High
₹10,064.00
Low
₹9,863.00
Mkt. cap
2.67T
Avg. vol.
589.35K
Volume
611.34K
Dividend
0.30%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
91.33
52-wk high
₹10,064.00
52-wk low
₹5,647.50
EPS
₹110.20
Shares outstanding
265.47M
No. of employees
12K
News stories
From web sources and news partners
FXStreet
·
6 minutes ago
Dow Jones Industrial Average falls on Apple's margin forecast
Investing.com
·
52 minutes ago
S&P 500 Santa Claus rally: what history says and where the index stands
Investing.com
·
21 minutes ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.46%
Yahoo Finance
·
3 hours ago
Netflix Trades at a Discount to the S&P 500's Valuation. Is It Deserved?
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd
CEOKiran S. Divi
Employees11.6K
FoundedOct 12, 1990
Headquarters-
SectorHealth care
Industry-
Websitedivislabs.com